EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Enzo Biochem's Enterprise Value is $2.78 Mil.
Enzo Biochem's EBIT for the trailing twelve months (TTM) ended in Jan. 2024 was $-4.54 Mil. Therefore, Enzo Biochem's EV-to-EBIT for today is -0.61.
The historical rank and industry rank for Enzo Biochem's EV-to-EBIT or its related term are showing as below:
ENZ'
s EV-to-EBIT Range Over the Past 10 Years
Min: -522.54 Med: -12.99 Max: 250.69
Current: -0.61
During the past 13 years, the highest EV-to-EBIT of Enzo Biochem was 250.69. The lowest was -522.54. And the median was -12.99.
ENZ's EV-to-EBIT is ranked worse than 100% of 108
companies
in the Medical Diagnostics & Research industry
Industry Median: 20.19
vs ENZ: -0.61
Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Enzo Biochem's Enterprise Value for the quarter that ended in Jan. 2024 was $10.56 Mil.
Enzo Biochem's EBIT for the trailing twelve months (TTM) ended in Jan. 2024 was $-4.54 Mil. Enzo Biochem's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jan. 2024 was -42.99%.
Enzo Biochem EV-to-EBIT Historical Data
The historical data trend for Enzo Biochem's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Enzo Biochem's EV-to-EBIT
For the Diagnostics & Research subindustry, Enzo Biochem's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Enzo Biochem's EV-to-EBIT Distribution in the Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Enzo Biochem's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Enzo Biochem's EV-to-EBIT falls into.
Enzo Biochem EV-to-EBIT Calculation
Enzo Biochem's EV-to-EBIT for today is calculated as:
Enzo Biochem's current Enterprise Value is $2.78 Mil.
Enzo Biochem's EBIT for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-4.54 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enzo Biochem (NYSE:ENZ) EV-to-EBIT Explanation
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Enzo Biochem's Enterprise Value for the quarter that ended in Jan. 2024 was $10.56 Mil.
Enzo Biochem's EBIT for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-4.54 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enzo Biochem EV-to-EBIT Related Terms
Thank you for viewing the detailed overview of Enzo Biochem's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.
Enzo Biochem Inc is a bioscience company. The firm manufactures, develops and sell their proprietary solutions and platforms to clinical laboratories, specialty clinics and researchers and physicians internationally. It focuses on delivering and applying its technology to produce products and services to allow its customers to meet their clinical needs. The company has Enzo clinical labs, Enzo life sciences, Enzo therapeutics operating segments. It derives the majority of its revenues from the Clinical lab's segment.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ENZ has been successfully added to your 